Kailiang Zhang Selected Research

Kailiang Zhang Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 10/2011
17	Glioma (Gliomas) 01/2023 - 10/2011
6	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2011
5	Glioblastoma (Glioblastoma Multiforme) 02/2015 - 06/2012
4	Carcinogenesis 01/2021 - 12/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 05/2015
2	Osteoarthritis 01/2023 - 12/2019
2	Wounds and Injuries (Trauma) 01/2023 - 01/2017
2	Cardiomegaly (Heart Hypertrophy) 11/2020 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2017 - 05/2014
2	Stomach Neoplasms (Stomach Cancer) 07/2016 - 09/2013
2	Astrocytoma (Pilocytic Astrocytoma) 04/2015 - 12/2011
2	Breast Neoplasms (Breast Cancer) 01/2015 - 09/2013
1	Tendinopathy (Tendonitis) 01/2023
1	Atherosclerosis 01/2022
1	Rupture 06/2021
1	Heart Failure 11/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Mitral Valve Insufficiency (Mitral Regurgitation) 02/2017
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2017
1	Cardiotoxicity 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Carcinoma (Carcinomatosis) 01/2014
1	Lymphoma (Lymphomas) 01/2014
1	Mucoepidermoid Carcinoma 11/2011

Drug/Important Bio-Agent (IBA)

12	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2011
9	CateninsIBA 01/2017 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2015
3	Long Noncoding RNAIBA 06/2021 - 06/2012
3	Messenger RNA (mRNA)IBA 01/2020 - 06/2012
2	Lysine (L-Lysine)FDA Link 01/2021 - 01/2015
2	LuciferasesIBA 01/2020 - 12/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2012
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017 - 05/2014
2	Small Interfering RNA (siRNA)IBA 01/2015 - 10/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 08/2012
2	Cadherins (E-Cadherin)IBA 04/2014 - 09/2013
1	isocorydineIBA 01/2024
1	Adenosine Triphosphate (ATP)IBA 01/2024
1	Matrix Metalloproteinases (MMPs)IBA 01/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024
1	EnzymesIBA 01/2024
1	Small Cytoplasmic RNAIBA 01/2023
1	Collagenases (Collagenase)FDA Link 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2023
1	oil red OIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Oxygen (Dioxygen)IBA 06/2021
1	LipidsIBA 06/2021
1	Fenofibrate (CiL)FDA LinkGeneric 06/2021
1	PPAR alphaIBA 06/2021
1	ChromatinIBA 01/2021
1	oligomycin sensitivity-conferring protein (complex V)IBA 11/2020
1	Surface Antigens (Surface Antigen)IBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	N-(3,4,5-trichlorophenyl)succinimideIBA 02/2017
1	Amifostine (Ethyol)FDA LinkGeneric 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2017
1	honokiolIBA 01/2017
1	evodiamineIBA 07/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2015
1	Emodin (Archin)IBA 05/2015
1	Small Nucleolar RNA (snoRNA)IBA 02/2015
1	NanocapsulesIBA 01/2015
1	Polycomb Repressive Complex 2IBA 01/2015
1	WP1066IBA 05/2014
1	IgA receptor (protein B)IBA 01/2014
1	bcl-X ProteinIBA 01/2014
1	Positive Regulatory Domain I-Binding Factor 1IBA 05/2013
1	beta CateninIBA 12/2012
1	Jagged-1 ProteinIBA 11/2012
1	Temozolomide (Temodar)FDA LinkGeneric 01/2012
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2011
1	Transcription Factor 4IBA 10/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2011

Therapy/Procedure

10	Therapeutics 01/2021 - 12/2012
1	Wearable Electronic Devices 01/2023
1	Electrodes (Electrode) 01/2023
1	Bandages (Bandage) 01/2023
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Sutures (Suture) 02/2017
1	Radiotherapy 07/2016
1	Drug Therapy (Chemotherapy) 01/2012
1	Injections 11/2011